Here is What Hedge Funds Think About BiomX Inc. (PHGE)
A whopping number of 13F filings filed with U.S.
Biomx Inc. (PHGE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 2,494,108 | $1,385,976 | +40% | 0.03% |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,493,309 | $1,385,532 | +45% | 0.06% |
| 3. | OrbiMed Advisors Samuel Isaly | 1,787,767 | $993,462 | 0.02% | |
| 4. | Alyeska Investment Group Anand Parekh | 1,590,738 | $883,973 | +84% | 0% |
| 5. | AIGH Investment Partners Orin Hirschman | 1,566,944 | $870,750 | +82% | 0.36% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.27 | 3,192 | $871.74 | 10,914 | 2023-05-22 | Filing | |
| $0.28 | 6,521 | $1,831.75 | 7,722 | 2023-05-19 | Filing | |
| $0.27 | 1,201 | $327.51 | 1,201 | 2023-05-18 | Filing | |
| $0.25 | 348,000 | $85,260.00 | 3,161,489 | 2023-02-27 | Filing | |
| $0.00 | 37,500 | $0.00 | 372,717 | 2021-07-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.38 | 24,344 | $9,279.93 | 13,773,653 | 2024-05-15 | Filing | |
| $0.34 | 2,056 | $699.04 | 0 | 2023-11-29 | Filing | |
| $0.35 | 3,414 | $1,194.90 | 2,056 | 2023-11-29 | Filing | |
| $0.40 | 5,444 | $2,177.60 | 5,470 | 2023-11-29 | Filing | |
| $0.38 | 1,501 | $567.38 | 2,997,025 | 2022-11-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 940,629 | $522,708 | 0.75% | |
| 2. | 430,000 | $238,951 | 0% | |
| 3. | 237,376 | $131,910 | 0% | |
| 4. | 99,616 | $55,357 | 0.01% | |
| 5. | 96,866 | $53,828 | 0.02% |
News See All
Hedge Funds Cautiously Watching BiomX Inc. (PHGE)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Hedge Funds
